Iovance Biotherapeutics, Inc. (IOVA)
8.07
-0.22
(-2.65%)
USD |
NASDAQ |
Aug 24, 16:00
8.05
-0.02
(-0.25%)
After-Hours: 20:00
Iovance Biotherapeutics Total Assets (Quarterly) : 915.53M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 915.53M |
| March 31, 2026 | 925.66M |
| December 31, 2025 | 913.17M |
| September 30, 2025 | 904.95M |
| June 30, 2025 | 907.44M |
| March 31, 2025 | 966.74M |
| December 31, 2024 | 910.43M |
| September 30, 2024 | 991.12M |
| June 30, 2024 | 964.32M |
| March 31, 2024 | 869.83M |
| December 31, 2023 | 780.35M |
| September 30, 2023 | 852.32M |
| June 30, 2023 | 757.29M |
| March 31, 2023 | 824.77M |
| December 31, 2022 | 663.98M |
| September 30, 2022 | 545.92M |
| June 30, 2022 | 610.88M |
| March 31, 2022 | 701.25M |
| December 31, 2021 | 777.33M |
| September 30, 2021 | 828.82M |
| June 30, 2021 | 852.79M |
| March 31, 2021 | 750.57M |
| December 31, 2020 | 768.46M |
| September 30, 2020 | 782.29M |
| June 30, 2020 | 817.57M |
| Date | Value |
|---|---|
| March 31, 2020 | 288.30M |
| December 31, 2019 | 344.66M |
| September 30, 2019 | 395.75M |
| June 30, 2019 | 435.92M |
| March 31, 2019 | 461.50M |
| December 31, 2018 | 480.82M |
| September 30, 2018 | 270.83M |
| June 30, 2018 | 284.75M |
| March 31, 2018 | 307.25M |
| December 31, 2017 | 155.37M |
| September 30, 2017 | 173.97M |
| June 30, 2017 | 138.01M |
| March 31, 2017 | 155.39M |
| December 31, 2016 | 171.89M |
| September 30, 2016 | 182.32M |
| June 30, 2016 | 193.54M |
| March 31, 2016 | 100.77M |
| December 31, 2015 | 105.65M |
| September 30, 2015 | 112.22M |
| June 30, 2015 | 114.74M |
| March 31, 2015 | 113.54M |
| December 31, 2014 | 46.51M |
| September 30, 2014 | 17.42M |
| June 30, 2014 | 18.54M |
| March 31, 2014 | 18.08M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Neurocrine Biosciences, Inc. | 5.359B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 179.49M |
| Shareholders Equity (Quarterly) | 736.04M |
| Debt to Equity Ratio | 0.0625 |
| Current Ratio | 4.345 |
| Net Debt Paydown Yield | 0.08% |